Hydrochlorothiazide and Prevention of Kidney-Stone RecurrenceNasser A. Dhayat, Daniel G. Fuster, Giulia Bedino et al.|New England Journal of Medicine|2023Cited by 128
Efficacy of standard and low dose hydrochlorothiazide in the recurrence prevention of calcium nephrolithiasis (NOSTONE trial): protocol for a randomized double-blind placebo-controlled trialNasser A. Dhayat, Daniel G. Fuster, Nicolas Faller et al.|BMC Nephrology|2018Cited by 33
Empagliflozin in nondiabetic individuals with calcium and uric acid kidney stones: a randomized phase 2 trialManuel Anderegg, Daniel G. Fuster, Simeon Schietzel et al.|Nature Medicine|2025Cited by 25
Indapamide or chlorthalidone to reduce urine supersaturation for secondary prevention of kidney stones: protocol for a randomised, double-blind, cross-over trial (INDAPACHLOR)Martin Scoglio, Daniel G. Fuster, Matteo Bargagli et al.|BMJ Open|2025Cited by 2